RESPIRATORY VIRAL INFECTION
Clinical trials for RESPIRATORY VIRAL INFECTION explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY VIRAL INFECTION trials appear
Sign up with your email to follow new studies for RESPIRATORY VIRAL INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug fights common cold to protect vulnerable lungs
Disease control CompletedThis study tested an experimental drug called vapendavir to see if it could reduce serious lung symptoms in people with COPD after they caught a common cold virus. Researchers gave the drug or a placebo to 52 adults with moderate COPD who were then exposed to the virus. The main …
Matched conditions: RESPIRATORY VIRAL INFECTION
Phase: PHASE2 • Sponsor: Altesa Biosciences, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
First-of-its-Kind trial aims to stop sickness at the tap for millions of well water users
Prevention CompletedThis study tested whether installing an ultraviolet (UV) light water treatment system in homes with private wells could reduce stomach bugs and respiratory infections in children under 5. Researchers compared families using treated water to those using untreated well water. They …
Matched conditions: RESPIRATORY VIRAL INFECTION
Phase: NA • Sponsor: Temple University • Aim: Prevention
Last updated Mar 20, 2026 14:48 UTC
-
Dietary supplement tested to block severe COVID-19 after exposure
Prevention CompletedThis study tested whether a dietary supplement called Mito-MES could prevent people from getting severely sick after being exposed to a virus like COVID-19. Researchers enrolled 80 healthy adults who had recently been exposed to someone with a respiratory illness. Some participan…
Matched conditions: RESPIRATORY VIRAL INFECTION
Phase: PHASE1, PHASE2 • Sponsor: University of California, Los Angeles • Aim: Prevention
Last updated Mar 09, 2026 14:26 UTC